Emma Reeve
Chief Financial Officer, PAREXEL INTERNATIONAL CORP.
Companies
- Whitehawk Therapeutics, Inc.Board member Sep 10, 2021 to now1
- PTC TherapeuticsBoard member Dec 18, 2018 to now2
- Editas MedicineBoard member Sep 8, 2021 to Jun 3, 20243
- Constellation Pharmaceuticals (United States)Chief financial officer Jul 18, 2018 to Jul 19, 20214
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
PTC Therapeutics PTCT10,666 shares5$650.5K at $60.99Jan 5, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jan 5, 2026Sold 734 shares at $76.00 of PTC Therapeutics5
- Jan 5, 2026Exercised options 734 shares at $46.54 of PTC Therapeutics5
- Jan 2, 2026Granted 4,000 shares of PTC Therapeutics5
- Dec 3, 2025Sold 733 shares at $78.62 of PTC Therapeutics6
- Dec 3, 2025Exercised options 733 shares at $46.54 of PTC Therapeutics6
- Nov 21, 2025Sold 10,000 shares at $79.50 of PTC Therapeutics7
- Nov 21, 2025Exercised options 10,000 shares at $51.16 of PTC Therapeutics7
- Nov 12, 2025Sold 7,333 shares at $74.50 of PTC Therapeutics8
- Nov 12, 2025Exercised options 7,333 shares at $46.54 of PTC Therapeutics8
- Oct 30, 2025Sold 12,000 shares at $69.50 of PTC Therapeutics9
- Oct 30, 2025Exercised options 12,000 shares at $38.10 of PTC Therapeutics9
- Oct 30, 2025Sold 3,666 shares at $69.50 of PTC Therapeutics9
- Oct 3, 2025Sold 1,884 shares at $66.89 of PTC Therapeutics10
- Oct 3, 2025Sold 4,037 shares at $66.10 of PTC Therapeutics10
- Oct 3, 2025Sold 2,729 shares at $65.05 of PTC Therapeutics10
- Oct 3, 2025Exercised options 8,650 shares at $33.63 of PTC Therapeutics10
- Oct 3, 2025Sold 1,600 shares at $66.93 of PTC Therapeutics10
- Oct 3, 2025Sold 3,149 shares at $66.11 of PTC Therapeutics10
- Oct 3, 2025Sold 2,163 shares at $65.02 of PTC Therapeutics10
- Oct 3, 2025Exercised options 6,912 shares at $33.02 of PTC Therapeutics10
- Oct 3, 2025Sold 2,381 shares at $66.87 of PTC Therapeutics10
- Oct 3, 2025Sold 4,591 shares at $66.09 of PTC Therapeutics10
- Oct 3, 2025Sold 3,028 shares at $65.09 of PTC Therapeutics10
- Oct 3, 2025Exercised options 10,000 shares at $39.42 of PTC Therapeutics10
- Sep 11, 2025Sold 837 shares at $59.50 of PTC Therapeutics11
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARPTC Therapeutics, Board member
- 3SEC EDGAREditas Medicine, Board member
- 4
- 5
- 6SEC EDGARForm 4 filed Dec 5, 2025
- 7SEC EDGARForm 4 filed Nov 25, 2025
- 8SEC EDGARForm 4 filed Nov 14, 2025
- 9SEC EDGARForm 4 filed Oct 31, 2025
- 10SEC EDGARForm 4 filed Oct 7, 2025
- 11SEC EDGARForm 4 filed Sep 16, 2025